Brief: Windlas Biotech Approves Buyback Of Shares Worth Up To 470 Million Rupees
17/04/2026 09:35
April 17 (Reuters) - Windlas Biotech Ltd WINL.NS: APPROVAL FOR BUYBACK OF SHARES WORTH UP TO 470 MILLION RUPEES BUYBACK PRICE SET AT 1,000 RUPEES PER EQUITY SHARE Source text: ID:nBSE7Lz2w9 Further company coverage: WINL.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Windlas Biotech
See all newsBrief: Windlas Biotech Approves Buyback Of Shares Worth Up To 470 Million Rupees
Brief: Windlas Biotech Dec-Quarter Consol Net Profit 150 Million Rupees
Brief: Windlas Biotech June-Quarter Consol Net Profit 176.6 Million Rupees
Brief: Windlas Biotech Gets GMP Certification For New Injectable Facility
Brief: Windlas Biotech June-Quarter Consol Net Profit 134.8 Mln Rupees